Year 2019, Volume 4 , Issue 2, Pages 74 - 78 2019-08-30

Pregnancy and Toxoplasmosis: should screening be a routine practice?
Gebelik ve Toksoplazmoz: Rutin tarama yapılmalı mı?

Esra Cinar Tanriverdi [1] , Zulal Ozkurt [2] , Yasemin Cayir [3] , Hakan Uslu [4]


Because infectious agents can reach the fetus through the placenta, pregnancy is regarded as a particular period for contagious diseases. Identification of infections during pregnancy and appropriate treatment can prevent fetal disorders. For this purpose, to avoid their harmful effects on fetus and newborn, various infectious diseases are screened during pregnancy. Toxoplasma gondii infection in pregnancy is transmitted through the transplacental pathway leading to severe neurological sequelae such as fetal abortion, stillbirth, intrauterine growth retardation, cranial calcifications, blindness, deafness, and mental retardation. This can lead to serious social and economic problems for the family and the infant, as well as society. To prevent these sequelae, infections during pregnancy need to be identified and appropriately treated. There are different opinions and practices in the world regarding the screening of T. gondii during pregnancy follow-up. This review aimed to assess the seroprevalence of T. gondii infection during gestation in Turkey and the world, its effects on the fetus, ways of protection, and suggestions about screening in the world and in Turkey in light of the literature, so that this becomes a guide for clinical practice for physicians.

Gebelik, etkenlerin transplasental yolla fetüse ulaşıp, hastalık yapabilme potansiyelleri nedeniyle enfeksiyon hastalıkları için özel bir dönemdir. Enfeksiyon etkenlerinin anneden bebeğe geçerek hastalık oluşturmalarının önlenmesi, gebelik sırasında tanınmaları ve uygun şekilde tedavi edilmelerine bağlıdır.  Bu amaçla, gebelik sırasında çeşitli enfeksiyon hastalıklar için tarama yapılmakta, fetüs ve yenidoğanda olabilecek hastalık ve olumsuz etkiler önlenmeye çalışılmaktadır. Gebelerde T. gondii taraması konusunda dünyada farklı görüş ve uygulamalar vardır. Bu derlemede, gebelikte T. gondii enfeksiyonunun dünyada ve Türkiye’de seroprevalansı, fetüs üzerine etkileri, korunma yolları,  tarama konusundaki görüş ve önerilerin literatür eşliğinde gözden geçirilmesi, birinci basamak hekimleri için klinik uygulamalarda yol gösterici olması amaçlanmıştır. 

  • 1. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J İnfect Dis. 2002;185(Supplement_1):P73-82. ‎ https://doi.org/10.1086/338827
  • 2. Hegab SM, Al-Mutawa SA. Immunopathogenesis of toxoplasmosis. Clin and Exp Med. 2003;3(2):84-105. ‎ https://doi.org/10.1007/s10238-003-0011-2
  • 3. Saricaoglu EM, Memikoglu KO. [Pregnancy and Toxoplasmosis]. (in Turkish). Journal of Ankara University Faculty Medicine. 2018; 71:17-22. http://dergiler.ankara.edu.tr/dergiler/36/2263/23548.pdf
  • 4. ‎Zeteroglu S. Toksoplazmosis. In: Intrauterine infections; Parasitic Infections, Cicek N, Akyurek C, Celik C, Haberal A (editors). Gynecology and Obstetrics Textbook, 2th ed, chp 64. Gunes Publishing, Istanbul, 2006;P720-72.‎
  • 5. Yazar S, Yaman O, Sahin I. [Evaluation of the Results of IgG Avidity Testing of Toxoplasma gondii in Pregnant Women] (in Turkish) Turkiye Parazitol Derg 2005; 29(4):221-3. http://parazitoloji.dergisi.org/pdf/pdf_TPD_1.pdf
  • 6. ‎Tanriverdi EÇ, Kadioglu BG, Alay H, Ozkurt Z. Retrospective Evaluation of Anti-Toxoplasma gondii Antibody Among First Trimester ‎Pregnant Women Admitted to Nenehatun Maternity Hospital between 2013-2017 in Erzurum. Turkiye Parazitol Derg, 2018; 42(2):‎‎101-5. http://cms.galenos.com.tr/Uploads/Article_21627/TPD-42-101-En.pdf
  • 7. ‎Montaya JG, Remington JS. Toxoplasma gondii. Fifth edition. New York, Churchill Livingstone. 2001;p30.‎
  • 8. ‎Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bulletin of the World Health ‎Organization. 2013; 91:501-8. https://www.who.int/bulletin/volumes/91/7/12-111732.pdf
  • 9. ‎Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol İnfect, 2002. 8(10):634-40. ‎ https://doi.org/10.1046/j.1469-0691.2002.00485.x
  • 10. ‎Liu Q, Wei F, Gao S, Jiang L, Lian H, Yuan B, et al. Toxoplasma gondii infection in pregnant women in China. Trans R Soc Trop Med ‎Hyg. 2009; 103(2):162-6. https://doi.org/10.1016/j.trstmh.2008.07.008
  • 11. ‎Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection ‎rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin. Vaccine Immunol. 2012. 19(3):365-7. ‎ https://www.ncbi.nlm.nih.gov/pubmed/22205659
  • 12. Khurana S, Bagga R, Aggarwal A, Lyngdoh V, Diddi K, Malla N. Serological screening for antenatal toxoplasma infection in India. J ‎Med Microbiol. 2010. 28(2):143-6. https://doi.org/10.4103/0255-0857.62492 13. ‎Bakacak M, Bostanci MS, Kostu B, Ercan O, Serin S, Avci F. [Seroprevalance of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women] (in Turkish). Dicle Med J, 2014; 41(2):326-31. https://doi.org/10.5798/diclemedj.0921.2014.02.0425
  • 14. ‎Tekay F, Ozbek E. [The Seroprevalence of Toxoplasma gondii in Women from Sanliurfa, a Province with a High Raw Meatball Consumption] (in Turkish). Turkiye Parazitol Derg. ‎‎2007;31(3):176-9. http://www.parazitoloji.dergisi.org/pdf/pdf_TPD_266.pdf
  • 15. ‎Madazli R. Toxoplasma Infection. İstanbul; İstanbul Medical Publishing; 2017; p310. http://tmftp.org/webkontrol/uploads/files/GebelikteTaramaveOngoru.pdf
  • 16. ‎Montoya JG, Toxoplasma gondii. Wilson WR, Sande MA ed. Dundar IH translation ed. [Infectious diseases, diagnosis, and treatment]. 1st ed. ‎Istanbul: Nobel Medical Publishing, 2004; 807–16.‎
  • 17. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, et al. Prenatal education for congenital toxoplasmosis. Cochrane ‎Database of Systematic Reviews. 2013;(2): CD006171. https://doi.org/10.1002/14651858.CD006171.pub3
  • 18. Remington JS, Klein JO, Alpert JJ. Current concepts of infections of the fetus and newborn infant. In Infectious diseases of the fetus and newborn infant. WB Saunders ed. 2001. P9.
  • 19. ‎Bahar IH, Karaman M, Kirdar S, Yilmaz O, Celiloglu M, Mutlu D. [The Importance and Validity of anti-Toxoplasma gondii IgG, IgM, IgA Antibodies and IgG Avidity Tests in the Diagnosis of Toxoplasmosis Infection during Pregnancy] (in Turkish). Turkiye Parazitol Derg. 2005;29(2):76-9. ‎ http://parazitoloji.dergisi.org/pdf/pdf_TPD_103.pdf
  • 20. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital ‎toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007; 369 : 115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
  • 21. ‎Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S. et al. Toxoplasmosis in pregnancy: prevention, screening, and ‎treatment. J Obstet Gynaecol Can. 2013;35(1):78-9. https://doi.org/10.1016/S1701-2163(15)31053-7
  • 22. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii ‎infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 2001;183(8):1248-53. https://doi.org/10.1086/319672
  • 23. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) ‎toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol. 1997;35(1):174-8. ‎ https://jcm.asm.org/content/jcm/35/1/174.full.pdf
  • 24. American College of Obstetricians and Gynecologists. Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and ‎toxoplasmosis in pregnancy. Obstet Gynecol. 2015;125(6):1510-25. https://doi.org/10.1097/01.AOG.0000466430.19823.53
  • 25. Goldstein EJC, Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Inf Dis. ‎‎2008;47(4):554-66. https://doi.org/10.1086/590149
  • 26. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem. Inst. ‎Oswaldo Cruz. 2009;104(2):320-44. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735102/
  • 27. Bénard A, Salmi R. European Toxo Prevention Study Group (EUROTOXO).Survey of European programmes for the epidemiological ‎surveillance of congenital toxoplasmosis. Euro Surveill. 2008;10;13(15). pii:18834. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740836/
  • 28. Society of Obstetricians and Gynaecologists of Canada (SOGC) (2013b) Clinical Practice Guideline. Toxoplasmosis in Pregnancy: ‎Prevention, Screening, and Treatment. J Obstet Gynaecol Can 2013;35(1 eSuppl A):S1–S7. https://www.sogc.org/guidelines/toxoplasmosis-in-pregnancy-prevention-screening-and-treatment/
  • 29. Mittendorf R, Pryde P, Herschel M, Williams MA. Is routine antenatal toxoplasmosis screening justified in the United States? Statistical ‎considerations in the application of medical screening tests. Clin Obstet Gynecol. 1999;42(1):163-73. https://www.ncbi.nlm.nih.gov/pubmed/10073309
  • 30. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scandinavian j İnfect Dis. 2012;44(11):805-14. https://doi.org/10.3109/00365548.2012.693197
  • 31. Hokelek M, Uyar Y, Gunaydin M, Cetin M. [Investigation of Toxoplasma Antibodies Seroprevalence in Samsun Region] (in Turkish). J Exp Clin ‎Med. 2010;17(1):50-55. http://www.parazitoloji.dergisi.org/pdf/pdf_TPD_447.pdf
  • 32. Royal College of Obstetricians Gynecologists. http://www.rcog.org.uk/womens-health/clinical-guidance/infection-and-pregnancy-study-group-statement
  • 33. Centers for Disease Control and Prevention. Preventing congenital toxoplasmosis. Recommendations and reports. MMVR. 2000;49. ‎ https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm
  • 34. Turkish Ministry of Health, Institution of Public Health, Women and Reproductive Health Department. [Obstetric Care and Management Guideline].(in Turkish) 2018. Ankara. https://sbu.saglik.gov.tr/Ekutuphane/kitaplar/dogumonubakim.pdf
  • 35. Müngen E. Toxoplasmosis screening in pregnancy. Perinatal Journal. 2010;18(3):69-71. http://www.perinataldergi.com/Files/Archive/tr-TR/Articles/PD-1111.pdf
Primary Language en
Subjects Obstetrics and Gynecology, Primary Health Care
Published Date Aug 2019
Journal Section Review Article
Authors

Orcid: 0000-0001-8857-3986
Author: Esra Cinar Tanriverdi (Primary Author)
Institution: Ataturk University, Faculty of Medicine, Department of Medical Education, Erzurum, Turkey
Country: Turkey


Orcid: 0000-0001-5554-8768
Author: Zulal Ozkurt
Institution: Ataturk University Faculty of Medicine, Department of Infectious Diseases, Erzurum, Turkey
Country: Turkey


Orcid: 0000-0001-9133-5460
Author: Yasemin Cayir
Institution: Ataturk University Faculty of Medicine, Department of Family Medicine, Erzurum, Turkey
Country: Turkey


Orcid: 0000-0003-1478-7441
Author: Hakan Uslu
Institution: Ataturk University Faculty of Medicine, Department of Medical Microbiology, Erzurum, Turkey
Country: Turkey


Dates

Publication Date : August 30, 2019

Bibtex @review { fppc396866, journal = {Family Practice and Palliative Care}, issn = {2458-8865}, eissn = {2459-1505}, address = {}, publisher = {SERNEV}, year = {2019}, volume = {4}, pages = {74 - 78}, doi = {10.22391/fppc.396866}, title = {Pregnancy and Toxoplasmosis: should screening be a routine practice?}, key = {cite}, author = {Cinar Tanriverdi, Esra and Ozkurt, Zulal and Cayir, Yasemin and Uslu, Hakan} }
APA Cinar Tanriverdi, E , Ozkurt, Z , Cayir, Y , Uslu, H . (2019). Pregnancy and Toxoplasmosis: should screening be a routine practice?. Family Practice and Palliative Care , 4 (2) , 74-78 . DOI: 10.22391/fppc.396866
MLA Cinar Tanriverdi, E , Ozkurt, Z , Cayir, Y , Uslu, H . "Pregnancy and Toxoplasmosis: should screening be a routine practice?". Family Practice and Palliative Care 4 (2019 ): 74-78 <http://www.fppc.com.tr/en/issue/48029/396866>
Chicago Cinar Tanriverdi, E , Ozkurt, Z , Cayir, Y , Uslu, H . "Pregnancy and Toxoplasmosis: should screening be a routine practice?". Family Practice and Palliative Care 4 (2019 ): 74-78
RIS TY - JOUR T1 - Pregnancy and Toxoplasmosis: should screening be a routine practice? AU - Esra Cinar Tanriverdi , Zulal Ozkurt , Yasemin Cayir , Hakan Uslu Y1 - 2019 PY - 2019 N1 - doi: 10.22391/fppc.396866 DO - 10.22391/fppc.396866 T2 - Family Practice and Palliative Care JF - Journal JO - JOR SP - 74 EP - 78 VL - 4 IS - 2 SN - 2458-8865-2459-1505 M3 - doi: 10.22391/fppc.396866 UR - https://doi.org/10.22391/fppc.396866 Y2 - 2019 ER -
EndNote %0 Family Practice and Palliative Care Pregnancy and Toxoplasmosis: should screening be a routine practice? %A Esra Cinar Tanriverdi , Zulal Ozkurt , Yasemin Cayir , Hakan Uslu %T Pregnancy and Toxoplasmosis: should screening be a routine practice? %D 2019 %J Family Practice and Palliative Care %P 2458-8865-2459-1505 %V 4 %N 2 %R doi: 10.22391/fppc.396866 %U 10.22391/fppc.396866
ISNAD Cinar Tanriverdi, Esra , Ozkurt, Zulal , Cayir, Yasemin , Uslu, Hakan . "Pregnancy and Toxoplasmosis: should screening be a routine practice?". Family Practice and Palliative Care 4 / 2 (August 2019): 74-78 . https://doi.org/10.22391/fppc.396866
AMA Cinar Tanriverdi E , Ozkurt Z , Cayir Y , Uslu H . Pregnancy and Toxoplasmosis: should screening be a routine practice?. Fam Pract Palliat Care. 2019; 4(2): 74-78.
Vancouver Cinar Tanriverdi E , Ozkurt Z , Cayir Y , Uslu H . Pregnancy and Toxoplasmosis: should screening be a routine practice?. Family Practice and Palliative Care. 2019; 4(2): 78-74.